IE
Insider Edges

COMMODORE CAPITAL LP 13F portfolio summary

COMMODORE CAPITAL LP of COMMODORE CAPITAL LP has 33 current stock holdings with a reported portfolio value of $1.68B. The portfolio 1 year return is +164.16%. Top holdings include RLAY (13.37%), ELVN (9.90%), ALKS (9.36%), COGT (7.03%), AMLX (6.04%).

Back to investors

COMMODORE CAPITAL LP

COMMODORE CAPITAL LP
Latest filing: 2026-06-30

COMMODORE CAPITAL LP runs COMMODORE CAPITAL LP and currently holds 33 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $1.68B. Their top holdings are RLAY, ELVN, ALKS, COGT, AMLX. The top five represent 45.7% of reported portfolio weight. COMMODORE CAPITAL LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, COMMODORE CAPITAL LP initiated 2 new positions. They added to 3 existing positions. They trimmed 8 positions. Their current best-performing preview position is DFTX with returns of +148.89%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
RLAY13.4%
ELVN9.9%
ALKS9.4%
COGT7.0%
AMLX6.0%
Top 5: 45.7%
Portfolio Returns
1 Year
+164.16%
#0/1000
3 Year
+216.92%
#0/1000
5 Year
+238.97%
#0/1000

Portfolio Value

$1.68B

Alpha Score

196.4

#0 of 1000

Holdings

33

Showper page

33 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
RLAY
RELAY THERAPEUTICS INC
13.37%$3.84$19.44+406.25%
Trimmed
-29.41%
ELVN
ENLIVEN THERAPEUTICS INC
9.90%$19.93$59.82+200.15%
Held
ALKS
ALKERMES PLC
9.36%$28.72$48.33+68.28%
Trimmed
-28.57%
COGT
COGENT BIOSCIENCES INC
7.03%$19.74$36.73+86.07%
Added
+5.61%
AMLX
AMYLYX PHARMACEUTICALS INC
6.04%$13.17$38.66+193.55%
Held
DFTX
DEFINIUM THERAPEUTICS INC
5.60%$18.90$44.91+137.62%
Held
SYRE
SPYRE THERAPEUTICS INC
4.48%$23.08$106.49+361.40%
Trimmed
-55.72%
TNGX
TANGO THERAPEUTICS INC
4.19%$31.26$23.88-23.61%
New Buy
EYPT
EYEPOINT INC
3.92%$13.43$5.32-60.39%
Added
+62.83%
TYRA
TYRA BIOSCIENCES INC
3.57%$9.85$26.05+164.47%
Trimmed
-24.24%

Showing 1-10 of 33